Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Procter & Gamble Co Reaffirms FY 2013 Guidance


Thursday, 25 Oct 2012 06:58am EDT 

Procter & Gamble Co announced that it has maintained organic sales growth guidance in the range of 2% to 4% for fiscal 2013. Foreign exchange is expected to reduce sales growth by 2% to 3%, resulting in guidance for all-in net sales growth of in-line to up 1% versus the prior year. The Company also maintained core earnings per share (EPS) guidance in the range of $3.80 to $4.00 and raised all-in GAAP EPS guidance by $0.17 per share to a range of $3.78 to $4.02. The $0.17 per share increase is the estimated non-core holding gain resulting from P&G's purchase of the balance of P&G's Baby Care and Feminine Care joint venture in Iberia, which was completed on October 22, 2012. The transaction is expected to be roughly neutral to core EPS results this fiscal year as the ongoing benefits from full ownership of the business will be offset by one-time transitional costs. The all-in EPS range also includes non-core restructuring investments of $0.15 to $0.19 per share, consistent with the Company's prior outlook. The Company reported revenue of $83.7 billion in fiscal 2012. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenues of $84.37 billion and EPS of $3.91 for fiscal 2013. 

Company Quote

83.28
0.47 +0.57%
4:02pm EDT